Antiarrhythmic therapy in patients with paroxysmal and persistent atrial fibrillation: identification of achievable goals and assessment of available funds
Kanorskiĭ, S.G.
Kardiologiia 54(2): 70-74
2014
ISSN/ISBN: 0022-9040 PMID: 24888204 Document Number: 676725
One of the achievable goals of treatment of patients with paroxysmal and persistent atrial fibrillation should be to prevent the progression to permanent form of arrhythmia, which is associated with an increased risk of complications and worsening prognosis. The review presents easily identifiable predictors of progression of atrial fibrillation, reviews the available treatment options and their effectiveness and safety.
Document emailed within 1 workday
Related Documents
Snezhitsky, V.A.; Yatskevich, E.S.; Doroshenko, E.M.; Smirnov, V.Y.; Dolgoshey, T.S.; Rubinsky, A.Y. 2016: Homocysteine as a Prognostic Marker of Atrial Remodeling and Clinical Picture in Patients with Paroxysmal and Persistent Forms of Atrial Fibrillation Klinicheskaia Meditsina 94(1): 16-22Jazwinska-Tarnawska, E.; Orzechowska-Juzwenko, K.; Niewinski, P.; Rzemislawska, Z.; Loboz-Grudzien, K.; Dmochowska-Perz, M.; Slawin, J. 2001: The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment International Journal of Clinical Pharmacology and Therapeutics 39(7): 288-292
Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626
He, R.; Du, X.; Liu, S.W.; Sun, L.J.; Li, Y.; Zeng, H.; Li, Y.Y.; Sun, C.; Zhang, Y.; Ma, C.S.; Gao, W. 2016: Current status of antiarrhythmic drug use and safety assessment in Chinese patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 44(11): 935-939
Dabrowski, R.ł; Borowiec, A.; Janas, J.; Firek, B.; Kowalik, I.; Smolis-Bak, E.; Luczak, D.; Sosnowski, C.; Kazimierska, B.; Szwed, H. 2010: High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation Kardiologia Polska 68(8): 893-900
Banasiak, W.; Owczarek, I.; Metner, E.; Fuglewicz, A.; Pieróg, M.; Telichowski, A.; Molenda, W.; Lacheta, W.; Petruk-Kowalczak, J.; Kałka, D.; Ponikowski, P. 1997: Clinical significance of atrial signal-averaged electrocardiogram in patients with electrically-induced paroxysmal atrial fibrillation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(8): 102-106
Villani, M.; Iannucci, G.; Cangelosi, A.P.; Di Paolo, F.M.; Ciardo, R.; Baciarello, G. 1992: Paroxysmal atrial fibrillation in patients with chronic ischemic cardiopathy: a study of high-resolution atrial activation Giornale Italiano di Cardiologia 22(6): 715-722
Fernandes, S.; Paulo, S.ér.; Vizinho, R.; Carneiro, A.ón.V. 2004: The therapeutic approach to paroxysmal or persistent atrial fibrillation: rhythm control versus rate control. a review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(4): 599-611
Chen, D-you.; Cao, J.; Zhu, B-po. 2006: Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old Chinese Medical Sciences Journal 21(1): 16-19
Alboni, P.; Gianfranchi, L.; Pacchioni, F.; Pedaci, M. 2005: Antiarrhythmic drugs in patients with recurrent atrial fibrillation: where are we? Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(3): 169-174
Walczak, F.; Szumowski, Łu.; Urbanek, P.; Szufladowicz, E.; Bodalski, R.; Kuśmierczyk, B.; Maryniak, A.; Baranowski, R.ł; Kepski, R.; Bujnowska, E. 2004: Significance of the origin of the right upper pulmonary vein and antiarrhythmic agents in transformation of long-lasting atrial fibrillation to unsustained but repetitive atrial flutter or atrial tachycardia Kardiologia Polska 60(4): 407-414
Pritchett, E.L.; Hammill, S.C.; Reiter, M.J.; Lee, K.L.; McCarthy, E.A.; Zimmerman, J.M.; Shand, D.G. 1983: Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia American Journal of Cardiology 52(8): 1007-1012
Vomácka, Z.; Válka, L. 1988: Our experience with amiodarone administration to patients with paroxysmal atrial fibrillation Acta Universitatis Palackianae Olomucensis Facultatis Medicae 120: 283-288
Cargnelli, G.; Domeneghetti, F.; Ferrari, M.; Malacini, P.; Roberti, G. 1977: Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents International Journal of Clinical Pharmacology and Biopharmacy 15(8): 384-388
Demidova, M.M.; Tikhonenko, V.M. 2005: Circadian dynamics of heart rate variability in patients with paroxysmal form of atrial fibrillation Kardiologiia 45(3): 24-30
Palma, M.; Palma, G.; Palma, A. 1991: Concurrence of intra-atrial conduction disorders in the initiation of paroxysmal atrial fibrillation Minerva Cardioangiologica 39(1-2): 55-57
Bartkowiak, R.ła.; Wozakowska-Kapłon, B.; Janiszewska, G. 2010: Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion Kardiologia Polska 68(1): 48-54
Nedostup, A.V.; Maevskaia, I.V.; Stygar, O.I.; Sarkisova, N.D. 1991: Spontaneous restoration of cardiac rhythm in patients with a persistent form of atrial fibrillation Kardiologiia 31(3): 46-48
Bugueño, C.; Corbalán, R.; Braun, S.; Tapia, J.; Kramer, A.; Huete, I.; Chávez, A. 1998: Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation Revista Medica de Chile 126(6): 646-654
Miric, D.; Ljutic, D.; Eterović, D.; Hodzić, M.; Pavić, M. 1992: The sirocco wind increases the onset of paroxysmal atrial fibrillation in patients in the central Dalmatian coastal region Lijecnicki Vjesnik 114(5-8): 93-95